ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
  • Category
  • Region
U.S. (TOLL FREE)
+1 (315) 215-3225
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025
Published Date: March 2025
|
Report Code: QYRE-Auto-0H11765
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2022
BUY CHAPTERS

Global Pharmaceutical Contract Development and Manufacturing Organization Market Research Report 2025

Code: QYRE-Auto-0H11765
Report
March 2025
Pages:99
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Catalent
Recipharm
Jubilant Life Sciences
Patheon
Boehringer Ingelheim
Pfizer CentreOne
Aenova Group
Famar
Lonza Group
tesa Labtec
Tapemark
Arx
Cambrex
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Wuxi Biologics
Siegfried
Baxter Pharmaceutical Solutions
Center for Breakthrough Medicines (CBM)

Pharmaceutical Contract Development and Manufacturing Organization Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pharmaceutical Contract Development and Manufacturing Organization Market

Pharmaceutical Contract Development and Manufacturing Organization Market

The global market for Pharmaceutical Contract Development and Manufacturing Organization was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
A CDMO is a contract development and manufacturing organization, meaning they not only handle the outsourced manufacturing of drug substances, but also all of the innovation and development work that occurs prior to manufacturing one. This includes development, production and analysis, and pharmaceutical companies no longer need to build and staff dedicated innovation and manufacturing facilities.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Development and Manufacturing Organization, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Development and Manufacturing Organization.
The Pharmaceutical Contract Development and Manufacturing Organization market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Contract Development and Manufacturing Organization market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Development and Manufacturing Organization companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Contract Development and Manufacturing Organization Market Report

Report Metric Details
Report Name Pharmaceutical Contract Development and Manufacturing Organization Market
CAGR 5%
Segment by Type
  • API Development
  • Pharmaceutical Manufacturing
Segment by Application
  • Large Enterprise
  • SME
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Catalent, Recipharm, Jubilant Life Sciences, Patheon Inc., Boehringer Ingelheim, Pfizer Centreone, Aenova Group, Famar, Baxter Pharmaceutical Solutions, Lonza Group, Tesa Labtec, Tapemark, ARX LLC, Cambrex, Samsung Biologics, Fujifilm Diosynth Biotechnologies, WuXi Biologics, Center for Breakthrough Medicines (CBM), Siegfried AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical Contract Development and Manufacturing Organization company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Pharmaceutical Contract Development and Manufacturing Organization Market report?

Ans: The main players in the Pharmaceutical Contract Development and Manufacturing Organization Market are Catalent, Recipharm, Jubilant Life Sciences, Patheon Inc., Boehringer Ingelheim, Pfizer Centreone, Aenova Group, Famar, Baxter Pharmaceutical Solutions, Lonza Group, Tesa Labtec, Tapemark, ARX LLC, Cambrex, Samsung Biologics, Fujifilm Diosynth Biotechnologies, WuXi Biologics, Center for Breakthrough Medicines (CBM), Siegfried AG

What are the Application segmentation covered in the Pharmaceutical Contract Development and Manufacturing Organization Market report?

Ans: The Applications covered in the Pharmaceutical Contract Development and Manufacturing Organization Market report are Large Enterprise, SME

What are the Type segmentation covered in the Pharmaceutical Contract Development and Manufacturing Organization Market report?

Ans: The Types covered in the Pharmaceutical Contract Development and Manufacturing Organization Market report are API Development, Pharmaceutical Manufacturing

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 API Development
1.2.3 Pharmaceutical Manufacturing
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Large Enterprise
1.3.3 SME
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Perspective (2020-2031)
2.2 Global Pharmaceutical Contract Development and Manufacturing Organization Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Contract Development and Manufacturing Organization Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Contract Development and Manufacturing Organization Market Dynamics
2.3.1 Pharmaceutical Contract Development and Manufacturing Organization Industry Trends
2.3.2 Pharmaceutical Contract Development and Manufacturing Organization Market Drivers
2.3.3 Pharmaceutical Contract Development and Manufacturing Organization Market Challenges
2.3.4 Pharmaceutical Contract Development and Manufacturing Organization Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Development and Manufacturing Organization Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Development and Manufacturing Organization Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Contract Development and Manufacturing Organization Revenue
3.4 Global Pharmaceutical Contract Development and Manufacturing Organization Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Development and Manufacturing Organization Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Development and Manufacturing Organization Revenue in 2024
3.5 Global Key Players of Pharmaceutical Contract Development and Manufacturing Organization Head office and Area Served
3.6 Global Key Players of Pharmaceutical Contract Development and Manufacturing Organization, Product and Application
3.7 Global Key Players of Pharmaceutical Contract Development and Manufacturing Organization, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Development and Manufacturing Organization Breakdown Data by Type
4.1 Global Pharmaceutical Contract Development and Manufacturing Organization Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Contract Development and Manufacturing Organization Breakdown Data by Application
5.1 Global Pharmaceutical Contract Development and Manufacturing Organization Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size (2020-2031)
6.2 North America Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size (2020-2031)
7.2 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size (2020-2031)
9.2 Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.1.4 Catalent Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Recipharm
11.2.1 Recipharm Company Details
11.2.2 Recipharm Business Overview
11.2.3 Recipharm Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.2.4 Recipharm Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.2.5 Recipharm Recent Development
11.3 Jubilant Life Sciences
11.3.1 Jubilant Life Sciences Company Details
11.3.2 Jubilant Life Sciences Business Overview
11.3.3 Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.3.4 Jubilant Life Sciences Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.3.5 Jubilant Life Sciences Recent Development
11.4 Patheon Inc.
11.4.1 Patheon Inc. Company Details
11.4.2 Patheon Inc. Business Overview
11.4.3 Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.4.4 Patheon Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.4.5 Patheon Inc. Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.5.4 Boehringer Ingelheim Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Pfizer Centreone
11.6.1 Pfizer Centreone Company Details
11.6.2 Pfizer Centreone Business Overview
11.6.3 Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.6.4 Pfizer Centreone Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.6.5 Pfizer Centreone Recent Development
11.7 Aenova Group
11.7.1 Aenova Group Company Details
11.7.2 Aenova Group Business Overview
11.7.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.7.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.7.5 Aenova Group Recent Development
11.8 Famar
11.8.1 Famar Company Details
11.8.2 Famar Business Overview
11.8.3 Famar Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.8.4 Famar Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.8.5 Famar Recent Development
11.9 Baxter Pharmaceutical Solutions
11.9.1 Baxter Pharmaceutical Solutions Company Details
11.9.2 Baxter Pharmaceutical Solutions Business Overview
11.9.3 Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.9.4 Baxter Pharmaceutical Solutions Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.9.5 Baxter Pharmaceutical Solutions Recent Development
11.10 Lonza Group
11.10.1 Lonza Group Company Details
11.10.2 Lonza Group Business Overview
11.10.3 Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.10.4 Lonza Group Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.10.5 Lonza Group Recent Development
11.11 Tesa Labtec
11.11.1 Tesa Labtec Company Details
11.11.2 Tesa Labtec Business Overview
11.11.3 Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.11.4 Tesa Labtec Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.11.5 Tesa Labtec Recent Development
11.12 Tapemark
11.12.1 Tapemark Company Details
11.12.2 Tapemark Business Overview
11.12.3 Tapemark Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.12.4 Tapemark Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.12.5 Tapemark Recent Development
11.13 ARX LLC
11.13.1 ARX LLC Company Details
11.13.2 ARX LLC Business Overview
11.13.3 ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.13.4 ARX LLC Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.13.5 ARX LLC Recent Development
11.14 Cambrex
11.14.1 Cambrex Company Details
11.14.2 Cambrex Business Overview
11.14.3 Cambrex Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.14.4 Cambrex Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.14.5 Cambrex Recent Development
11.15 Samsung Biologics
11.15.1 Samsung Biologics Company Details
11.15.2 Samsung Biologics Business Overview
11.15.3 Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.15.4 Samsung Biologics Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.15.5 Samsung Biologics Recent Development
11.16 Fujifilm Diosynth Biotechnologies
11.16.1 Fujifilm Diosynth Biotechnologies Company Details
11.16.2 Fujifilm Diosynth Biotechnologies Business Overview
11.16.3 Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.16.4 Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.16.5 Fujifilm Diosynth Biotechnologies Recent Development
11.17 WuXi Biologics
11.17.1 WuXi Biologics Company Details
11.17.2 WuXi Biologics Business Overview
11.17.3 WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.17.4 WuXi Biologics Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.17.5 WuXi Biologics Recent Development
11.18 Center for Breakthrough Medicines (CBM)
11.18.1 Center for Breakthrough Medicines (CBM) Company Details
11.18.2 Center for Breakthrough Medicines (CBM) Business Overview
11.18.3 Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.18.4 Center for Breakthrough Medicines (CBM) Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.18.5 Center for Breakthrough Medicines (CBM) Recent Development
11.19 Siegfried AG
11.19.1 Siegfried AG Company Details
11.19.2 Siegfried AG Business Overview
11.19.3 Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Introduction
11.19.4 Siegfried AG Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
11.19.5 Siegfried AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Catalent
Recipharm
Jubilant Life Sciences
Patheon
Boehringer Ingelheim
Pfizer CentreOne
Aenova Group
Famar
Lonza Group
tesa Labtec
Tapemark
Arx
Cambrex
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Wuxi Biologics
Siegfried
Baxter Pharmaceutical Solutions
Center for Breakthrough Medicines (CBM)
List of Tables
 Table 1. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of API Development
 Table 3. Key Players of Pharmaceutical Manufacturing
 Table 4. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2020-2025)
 Table 8. Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2026-2031)
 Table 10. Pharmaceutical Contract Development and Manufacturing Organization Market Trends
 Table 11. Pharmaceutical Contract Development and Manufacturing Organization Market Drivers
 Table 12. Pharmaceutical Contract Development and Manufacturing Organization Market Challenges
 Table 13. Pharmaceutical Contract Development and Manufacturing Organization Market Restraints
 Table 14. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Players (2020-2025)
 Table 16. Global Top Pharmaceutical Contract Development and Manufacturing Organization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing Organization as of 2024)
 Table 17. Ranking of Global Top Pharmaceutical Contract Development and Manufacturing Organization Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Pharmaceutical Contract Development and Manufacturing Organization Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Pharmaceutical Contract Development and Manufacturing Organization, Headquarters and Area Served
 Table 20. Global Key Players of Pharmaceutical Contract Development and Manufacturing Organization, Product and Application
 Table 21. Global Key Players of Pharmaceutical Contract Development and Manufacturing Organization, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type (2020-2025)
 Table 25. Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Type (2026-2031)
 Table 27. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2020-2025)
 Table 29. Global Pharmaceutical Contract Development and Manufacturing Organization Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Pharmaceutical Contract Development and Manufacturing Organization Revenue Market Share by Application (2026-2031)
 Table 31. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Catalent Company Details
 Table 47. Catalent Business Overview
 Table 48. Catalent Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 49. Catalent Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 50. Catalent Recent Development
 Table 51. Recipharm Company Details
 Table 52. Recipharm Business Overview
 Table 53. Recipharm Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 54. Recipharm Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 55. Recipharm Recent Development
 Table 56. Jubilant Life Sciences Company Details
 Table 57. Jubilant Life Sciences Business Overview
 Table 58. Jubilant Life Sciences Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 59. Jubilant Life Sciences Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 60. Jubilant Life Sciences Recent Development
 Table 61. Patheon Inc. Company Details
 Table 62. Patheon Inc. Business Overview
 Table 63. Patheon Inc. Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 64. Patheon Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 65. Patheon Inc. Recent Development
 Table 66. Boehringer Ingelheim Company Details
 Table 67. Boehringer Ingelheim Business Overview
 Table 68. Boehringer Ingelheim Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 69. Boehringer Ingelheim Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 70. Boehringer Ingelheim Recent Development
 Table 71. Pfizer Centreone Company Details
 Table 72. Pfizer Centreone Business Overview
 Table 73. Pfizer Centreone Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 74. Pfizer Centreone Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 75. Pfizer Centreone Recent Development
 Table 76. Aenova Group Company Details
 Table 77. Aenova Group Business Overview
 Table 78. Aenova Group Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 79. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 80. Aenova Group Recent Development
 Table 81. Famar Company Details
 Table 82. Famar Business Overview
 Table 83. Famar Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 84. Famar Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 85. Famar Recent Development
 Table 86. Baxter Pharmaceutical Solutions Company Details
 Table 87. Baxter Pharmaceutical Solutions Business Overview
 Table 88. Baxter Pharmaceutical Solutions Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 89. Baxter Pharmaceutical Solutions Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 90. Baxter Pharmaceutical Solutions Recent Development
 Table 91. Lonza Group Company Details
 Table 92. Lonza Group Business Overview
 Table 93. Lonza Group Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 94. Lonza Group Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 95. Lonza Group Recent Development
 Table 96. Tesa Labtec Company Details
 Table 97. Tesa Labtec Business Overview
 Table 98. Tesa Labtec Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 99. Tesa Labtec Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 100. Tesa Labtec Recent Development
 Table 101. Tapemark Company Details
 Table 102. Tapemark Business Overview
 Table 103. Tapemark Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 104. Tapemark Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 105. Tapemark Recent Development
 Table 106. ARX LLC Company Details
 Table 107. ARX LLC Business Overview
 Table 108. ARX LLC Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 109. ARX LLC Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 110. ARX LLC Recent Development
 Table 111. Cambrex Company Details
 Table 112. Cambrex Business Overview
 Table 113. Cambrex Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 114. Cambrex Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 115. Cambrex Recent Development
 Table 116. Samsung Biologics Company Details
 Table 117. Samsung Biologics Business Overview
 Table 118. Samsung Biologics Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 119. Samsung Biologics Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 120. Samsung Biologics Recent Development
 Table 121. Fujifilm Diosynth Biotechnologies Company Details
 Table 122. Fujifilm Diosynth Biotechnologies Business Overview
 Table 123. Fujifilm Diosynth Biotechnologies Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 124. Fujifilm Diosynth Biotechnologies Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 125. Fujifilm Diosynth Biotechnologies Recent Development
 Table 126. WuXi Biologics Company Details
 Table 127. WuXi Biologics Business Overview
 Table 128. WuXi Biologics Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 129. WuXi Biologics Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 130. WuXi Biologics Recent Development
 Table 131. Center for Breakthrough Medicines (CBM) Company Details
 Table 132. Center for Breakthrough Medicines (CBM) Business Overview
 Table 133. Center for Breakthrough Medicines (CBM) Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 134. Center for Breakthrough Medicines (CBM) Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 135. Center for Breakthrough Medicines (CBM) Recent Development
 Table 136. Siegfried AG Company Details
 Table 137. Siegfried AG Business Overview
 Table 138. Siegfried AG Pharmaceutical Contract Development and Manufacturing Organization Product
 Table 139. Siegfried AG Revenue in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025) & (US$ Million)
 Table 140. Siegfried AG Recent Development
 Table 141. Research Programs/Design for This Report
 Table 142. Key Data Information from Secondary Sources
 Table 143. Key Data Information from Primary Sources
 Table 144. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical Contract Development and Manufacturing Organization Picture
 Figure 2. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Type: 2024 VS 2031
 Figure 4. API Development Features
 Figure 5. Pharmaceutical Manufacturing Features
 Figure 6. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Application: 2024 VS 2031
 Figure 8. Large Enterprise Case Studies
 Figure 9. SME Case Studies
 Figure 10. Pharmaceutical Contract Development and Manufacturing Organization Report Years Considered
 Figure 11. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Pharmaceutical Contract Development and Manufacturing Organization Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region: 2024 VS 2031
 Figure 14. Global Pharmaceutical Contract Development and Manufacturing Organization Market Share by Players in 2024
 Figure 15. Global Top Pharmaceutical Contract Development and Manufacturing Organization Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing Organization as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Organization Revenue in 2024
 Figure 17. North America Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2020-2031)
 Figure 19. United States Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2020-2031)
 Figure 23. Germany Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization Market Share by Region (2020-2031)
 Figure 31. China Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2020-2031)
 Figure 39. Mexico Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Organization Market Share by Country (2020-2031)
 Figure 43. Turkey Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Pharmaceutical Contract Development and Manufacturing Organization Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Catalent Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 47. Recipharm Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 48. Jubilant Life Sciences Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 49. Patheon Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 50. Boehringer Ingelheim Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 51. Pfizer Centreone Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 52. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 53. Famar Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 54. Baxter Pharmaceutical Solutions Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 55. Lonza Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 56. Tesa Labtec Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 57. Tapemark Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 58. ARX LLC Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 59. Cambrex Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 60. Samsung Biologics Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 61. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 62. WuXi Biologics Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 63. Center for Breakthrough Medicines (CBM) Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 64. Siegfried AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Organization Business (2020-2025)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Chrysalis Oil Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26N13078
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Eucommia Ulmoides Extract Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3L13782
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global MRSA Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26S13718
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Ferrous Citrate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16S12875
Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions